{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:28:23Z","timestamp":1792024103727,"version":"4.4.0"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Leukemia cutis is a conflicting term to describe neoplastic hematopoietic infiltrates in the skin. Cutaneous myeloid or lymphoid proliferations often present a serious differential diagnostic challenge for pathologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review aims to outline the confusion associated with the term leukemia cutis and discuss in detail the foremost common differential diagnoses in daily practice. The review is based on a summary of the relevant literature as well as on the authors\u2019 experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>It addresses precursor cell myeloid and lymphoid tumors that are strictly considered true leukemia cutis but also more mature neoplasms, including some recently described mature extramedullary myeloid proliferations. Finally, a practical, comprehensive stepwise approach combining traditional immunohistochemical marker panels, novel lineage- or mutational-specific markers, and other ancillary tests is suggested to reach an entity-specific diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The proper combination of ancillary techniques can help the pathologist to provide an accurate diagnosis of these challenging skin lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqae133","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:26:54Z","timestamp":1726446414000},"page":"395-405","source":"Crossref","is-referenced-by-count":19,"title":["Diagnostic approach to\n                    <i>leukemia cutis<\/i>\n                    : A differential diagnostic step-by-step algorithm"],"prefix":"10.1093","volume":"163","author":[{"given":"Alex","family":"Jenei","sequence":"first","affiliation":[{"name":"Department of Pathology and Experimental Cancer Research Semmelweis University, Faculty of Medicine , Budapest ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics and Pathology, University Hospital Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"1","key":"2025031001324090000_CIT0001","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11912-020-00919-6","article-title":"Leukemia cutis","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Am J Clin Pathol."},{"issue":"7","key":"2025031001324090000_CIT0002","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11912-020-00919-6","article-title":"Diagnostic and therapeutic considerations for extramedullary leukemia","volume":"22","author":"Bakst","year":"2020","journal-title":"Curr Oncol Rep."},{"issue":"3","key":"2025031001324090000_CIT0003","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/j.seminoncol.2016.02.020","article-title":"Cutaneous manifestations in leukemia patients","volume":"43","author":"Grunwald","year":"2016","journal-title":"Semin Oncol."},{"issue":"5","key":"2025031001324090000_CIT0004","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/HS9.0000000000000141","article-title":"Leukemia cutis in childhood acute myeloid leukemia: epidemiological, clinical, biological, and prognostic characteristics of patients included in the ELAM02 Study","volume":"2","author":"Gouache","year":"2018","journal-title":"Hemasphere"},{"issue":"10","key":"2025031001324090000_CIT0005","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.3324\/haematol.2015.129346","article-title":"NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features","volume":"100","author":"Luskin","year":"2015","journal-title":"Haematologica."},{"key":"2025031001324090000_CIT0006","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev."},{"issue":"22","key":"2025031001324090000_CIT0007","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.3390\/cancers15225393","article-title":"Leukemia cutis-the current view on pathogenesis, diagnosis, and treatment","volume":"15","author":"Robak","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2025031001324090000_CIT0008","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/cup.12553","article-title":"JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature","volume":"42","author":"LeBlanc","year":"2015","journal-title":"J Cutan Pathol."},{"issue":"4","key":"2025031001324090000_CIT0009","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5858\/arpa.2023-0132-RA","article-title":"Myelodysplasia cutis","volume":"148","author":"Whittington","year":"2024","journal-title":"Arch Pathol Lab Med."},{"issue":"1","key":"2025031001324090000_CIT0010","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000530940","article-title":"Progression in myeloid neoplasms: beyond the myeloblast","volume":"91","author":"Faria","year":"2024","journal-title":"Pathobiology."},{"issue":"11","key":"2025031001324090000_CIT0011","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.2967\/jnumed.108.055335","article-title":"First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine","volume":"49","author":"Buck","year":"2008","journal-title":"J Nucl Med."},{"issue":"6","key":"2025031001324090000_CIT0012","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"St\u00f6lzel","year":"2020","journal-title":"Haematologica."},{"issue":"1","key":"2025031001324090000_CIT0013","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2025031001324090000_CIT0014","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"Agis","year":"2002","journal-title":"Ann Hematol."},{"issue":"2","key":"2025031001324090000_CIT0015","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijrobp.2018.05.045","article-title":"Use of radiation in extramedullary leukemia\/chloroma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"102","author":"Bakst","year":"20181","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"2025031001324090000_CIT0016","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1610-0387.2011.07842.x","article-title":"Leukemia cutis\u2014epidemiology, clinical presentation, and differential diagnoses","volume":"10","author":"Wagner","year":"2012","journal-title":"J Dtsch Dermatol Ges."},{"issue":"3","key":"2025031001324090000_CIT0017","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5114\/ada.2021.107923","article-title":"Leukemia cutis for clinicians, a literature review","volume":"38","author":"Osmola","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"2025031001324090000_CIT0018","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review","volume":"21","author":"Maglie","year":"2020","journal-title":"Am J Clin Dermatol."},{"issue":"1","key":"2025031001324090000_CIT0019","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1309\/AJCP6GR8BDEXPKHR","article-title":"An updated approach to the diagnosis of myeloid leukemia cutis","volume":"132","author":"Cronin","year":"2009","journal-title":"Am J Clin Pathol."},{"issue":"5","key":"2025031001324090000_CIT0020","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev."},{"issue":"6","key":"2025031001324090000_CIT0021","first-page":"989","article-title":"Myeloid sarcoma: a clinicopathological study with emphasis on diagnostic difficulties","volume":"13","author":"Kudva","year":"2017","journal-title":"J Cancer Res Ther."},{"key":"2025031001324090000_CIT0022","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.2147\/OTT.S245828","article-title":"Isolated intracranial myeloid sarcoma mimicking malignant lymphoma: a diagnostic challenge and literature reviews","volume":"13","author":"Xu","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"7","key":"2025031001324090000_CIT0023","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia."},{"issue":"1","key":"2025031001324090000_CIT0024","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1309\/HDUE-DN2E-B72E-JK99","article-title":"Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia","volume":"116","author":"Arber","year":"2001","journal-title":"Am J Clin Pathol."},{"issue":"4","key":"2025031001324090000_CIT0025","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ajcp\/aqx021","article-title":"Clinical significance of isolated myeloperoxidase expression in pediatric B-lymphoblastic leukemia","volume":"147","author":"Oberley","year":"2017","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"2025031001324090000_CIT0026","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","article-title":"CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia","volume":"137","author":"Hoehn","year":"2012","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"2025031001324090000_CIT0027","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/path.1126","article-title":"Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma\/leukemias","volume":"197","author":"Hashimoto","year":"2002","journal-title":"J Pathol."},{"issue":"2-3","key":"2025031001324090000_CIT0028","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000493688","article-title":"RUNX1 mutations can lead to aberrant expression of CD79a and PAX5 in acute myelogenous leukemias: a potential diagnostic pitfall","volume":"86","author":"Menter","year":"2019","journal-title":"Pathobiology."},{"issue":"1","key":"2025031001324090000_CIT0029","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch."},{"issue":"15","key":"2025031001324090000_CIT0030","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3390\/cancers15153928","article-title":"Skin involvement by hematological neoplasms with blastic morphology: lymphoblastic lymphoma, blastoid variant of mantle cell lymphoma and differential diagnoses","volume":"15","author":"Zanelli","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2025031001324090000_CIT0031","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"2025031001324090000_CIT0032","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/DAD.0000000000000004","article-title":"A unique cutaneous presentation of Burkitt lymphoma","volume":"36","author":"Rogers","year":"2014","journal-title":"Am J Dermatopathol."},{"issue":"3","key":"2025031001324090000_CIT0033","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jaad.2017.08.054","article-title":"Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: a case series from Korea","volume":"78","author":"Woo","year":"2018","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"2025031001324090000_CIT0034","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3109\/10428194.2015.1128542","article-title":"Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients","volume":"57","author":"Jurczyszyn","year":"2016","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"2025031001324090000_CIT0035","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","article-title":"Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma","volume":"12","author":"Frontzek","year":"2021","journal-title":"Nat Commun."},{"issue":"11","key":"2025031001324090000_CIT0036","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1097\/PAS.0000000000000272","article-title":"T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"2025031001324090000_CIT0037","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/hematolrep15040070","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN): clinical features and histopathology with a therapeutic overview","volume":"15","author":"Cazzato","year":"2023","journal-title":"Hematol Rep"},{"issue":"7966","key":"2025031001324090000_CIT0038","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-023-06156-8","article-title":"Ultraviolet radiation shapes dendritic cell leukemia transformation in the skin","volume":"618","author":"Griffin","year":"2023","journal-title":"Nature."},{"issue":"2","key":"2025031001324090000_CIT0039","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol."},{"issue":"5","key":"2025031001324090000_CIT0040","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.18632","article-title":"Plasmacytoid dendritic cells in the setting of myeloid neoplasms: diagnostic guide to challenging pathologic presentations","volume":"200","author":"El Hussein","year":"2023","journal-title":"Br J Haematol."},{"issue":"5","key":"2025031001324090000_CIT0041","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ajcp\/aqac174","article-title":"Expanding the immunophenotypic spectrum of neoplastic and reactive plasmacytoid dendritic cells","volume":"159","author":"Wu","year":"2023","journal-title":"Am J Clin Pathol."},{"issue":"12","key":"2025031001324090000_CIT0042","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1182\/bloodadvances.2023012489","article-title":"Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms","volume":"8","author":"Mah\u00e9vas","year":"2024","journal-title":"Blood Adv."},{"issue":"14","key":"2025031001324090000_CIT0043","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.3390\/cancers14143375","article-title":"Immunophenotypic and molecular features of acute myeloid leukemia with plasmacytoid dendritic cell differentiation are distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2025031001324090000_CIT0044","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias","volume":"45","author":"Katz","year":"2021","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2025031001324090000_CIT0045","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.yexmp.2007.08.010","article-title":"Aberrant expression of T-cell markers in acute myeloid leukemia","volume":"83","author":"Lewis","year":"2007","journal-title":"Exp Mol Pathol."},{"issue":"11","key":"2025031001324090000_CIT0046","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood."},{"issue":"7","key":"2025031001324090000_CIT0047","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia."},{"issue":"12","key":"2025031001324090000_CIT0048","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1182\/blood-2010-01-266908","article-title":"A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias","volume":"116","author":"Gruszka","year":"2010","journal-title":"Blood."},{"issue":"8","key":"2025031001324090000_CIT0049","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajh.25544","article-title":"High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia","volume":"94","author":"Patel","year":"2019","journal-title":"Am J Hematol."},{"issue":"11","key":"2025031001324090000_CIT0050","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/exd.14013","article-title":"Cutaneous extramedullary haematopoiesis: implications in human disease and treatment","volume":"28","author":"Khalil","year":"2019","journal-title":"Exp Dermatol."},{"issue":"10","key":"2025031001324090000_CIT0051","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/ijd.16809","article-title":"Cutaneous involvement in PH-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature","volume":"62","author":"Bonometti","year":"2023","journal-title":"Int J Dermatol."},{"issue":"3","key":"2025031001324090000_CIT0052","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1053\/adpa.2002.34574","article-title":"Sclerosing extramedullary hematopoietic tumor","volume":"6","author":"Yang","year":"2002","journal-title":"Ann Diagn Pathol."},{"issue":"10","key":"2025031001324090000_CIT0053","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1034\/j.1600-0560.2002.291007.x","article-title":"Cutaneous sclerosing extramedullary hematopoietic tumor in chronic myelogenous leukemia","volume":"29","author":"Lane","year":"2002","journal-title":"J Cutan Pathol."},{"issue":"3","key":"2025031001324090000_CIT0054","first-page":"3381","article-title":"Sclerosing extramedullary hematopoietic tumor presenting as an inguinal mass in a patient with primary myelofibrosis: a diagnostic pitfall","volume":"8","author":"Gu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"2025031001324090000_CIT0055","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1182\/blood.2021014788","article-title":"Skin in the game: the emergence of myelodysplasia cutis","volume":"139","author":"Calvo","year":"2022","journal-title":"Blood."},{"issue":"8","key":"2025031001324090000_CIT0056","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.2021013967","article-title":"Clinical, pathological, and molecular features of myelodysplasia cutis","volume":"139","author":"Delaleu","year":"2022","journal-title":"Blood."},{"issue":"2","key":"2025031001324090000_CIT0057","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.det.2023.08.004","article-title":"From histiocytoid Sweet syndrome to myelodysplasia cutis: history and perspectives","volume":"42","author":"Vignon-Pennamen","year":"2024","journal-title":"Dermatol Clin."},{"issue":"9","key":"2025031001324090000_CIT0058","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1038\/jid.2015.146","article-title":"Myelodysplasia cutis versus leukemia cutis","volume":"135","author":"Osio","year":"2015","journal-title":"J Invest Dermatol."},{"issue":"3","key":"2025031001324090000_CIT0059","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cup.13910","article-title":"Merkel cell carcinoma: a review","volume":"48","author":"Walsh","year":"2021","journal-title":"J Cutan Pathol."},{"issue":"11","key":"2025031001324090000_CIT0060","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/DAD.0000000000001232","article-title":"A comparison of the histopathologic growth patterns between non-Merkel cell small round blue cell tumors and Merkel cell carcinoma","volume":"40","author":"Bandino","year":"2018","journal-title":"Am J Dermatopathol."},{"issue":"6","key":"2025031001324090000_CIT0061","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1309\/R494HQ9VRDJWDY30","article-title":"Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall","volume":"129","author":"Buresh","year":"2008","journal-title":"Am J Clin Pathol."},{"issue":"5","key":"2025031001324090000_CIT0062","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/01.pas.0000155162.33044.4f","article-title":"B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol."},{"issue":"8","key":"2025031001324090000_CIT0063","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/ced\/llad166","article-title":"Cutaneous sarcoma: a review and practical approach to management","volume":"48","author":"Stoneham","year":"2023","journal-title":"Clin Exp Dermatol."},{"issue":"1","key":"2025031001324090000_CIT0064","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/cup.12565","article-title":"Synovial sarcoma with cutaneous metastasis","volume":"43","author":"Achtman","year":"2016","journal-title":"J Cutan Pathol."},{"issue":"2","key":"2025031001324090000_CIT0065","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/DAD.0000000000002348","article-title":"Primary cutaneous Ewing sarcoma of the scalp with metastasis to the lung: an unusual manifestation during pregnancy","volume":"45","author":"Regmi","year":"2023","journal-title":"Am J Dermatopathol."},{"issue":"4","key":"2025031001324090000_CIT0066","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00000372-199908000-00016","article-title":"A case of soft tissue mesenchymal chondrosarcoma metastatic to skin, clinically mimicking keratoacanthoma","volume":"21","author":"Aramburu-Gonz\u00e1lez","year":"1999","journal-title":"Am J Dermatopathol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/3\/395\/59865038\/aqae133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/163\/3\/395\/59865038\/aqae133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T21:33:20Z","timestamp":1741556000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/163\/3\/395\/7826100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2025,3,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqae133","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,10,18]]}}}